Risk factors for inflammatory bowel disease in the general population

被引:115
|
作者
Rodríguez, LAG
González-Pérez, A
Johansson, S
Wallander, MA
机构
[1] Ctr Espanol Invest Farmacoepidemiol, Madrid, Spain
[2] AstraZeneca R&D, Molndal, Sweden
[3] Gothenburg Univ, Sect Prevent Cardiol, S-41124 Gothenburg, Sweden
[4] Univ Uppsala, Dept Publ Hlth & Caring Sci, S-75105 Uppsala, Sweden
关键词
D O I
10.1111/j.1365-2036.2005.02564.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The aetiology of inflammatory bowel disease remains largely unknown. Aim: We performed a comprehensive assessment of potential risk factors associated with the occurrence of inflammatory bowel disease. Methods:We identified a cohort of patients 20-84 years old between 1995 and 1997 registered in the General Practitioner Research Database in the UK. A total of 444 incident cases of IBD were ascertained and validated with the general practitioner. We performed a nested case-control analysis using all cases and a random sample of 10 000 frequency-matched controls. Results: Incidence rates for ulcerative colitis, Crohn's disease, and indeterminate colitis were 11, 8, and 2 cases per 100 000 person-years, respectively. Among women, we found that long-term users of oral contraceptives were at increased risk of developing UC (OR: 2.35; 95% CI: 0.89-6.22) and CD (OR: 3.15; 95% CI: 1.24-7.99). Similarly, long-term users of HRT had an increased risk of CD (OR: 2.60; 95% CI: 1.04-6.49) but not UC. Current smokers experienced a reduced risk of UC along with an increased risk of CD. Prior appendectomy was associated with a decreased the risk of UC (OR: 0.37; 95% CI: 0.14-1.00). Conclusions: Our results support the hypothesis of an increased risk of inflammatory bowel disease associated with oral contraceptives use and suggest a similar effect of hormone replacement therapy on CD. We also confirmed the effects of smoking and appendectomy on inflammatory bowel disease.
引用
下载
收藏
页码:309 / 315
页数:7
相关论文
共 50 条
  • [41] Risk of drug interactions in population of patients with inflammatory bowel disease
    Cerveny, Petr
    Vlcek, Jiri
    Lukas, Milan
    Bortlik, Martin
    [J]. PHARMACY WORLD & SCIENCE, 2009, 31 (01): : 127 - 127
  • [42] Diet and Anthropometrics of Children With Inflammatory Bowel Disease: A Comparison With the General Population
    Diederen, Kay
    Krom, Hilde
    Koole, Jeffrey C. D.
    Benninga, Marc A.
    Kindermann, Angelika
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (08) : 1632 - 1640
  • [43] Inflammatory bowel disease: epidemiology and management in an English general practice population
    Rubin, GP
    Hungin, APS
    Kelly, PJ
    Ling, J
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (12) : 1553 - 1559
  • [44] RISK FACTORS FOR INCIDENT INFLAMMATORY BOWEL DISEASE ACCORDING TO DISEASE PHENOTYPE
    Lopes, Emily W.
    Burke, Kristin E.
    Richter, James
    Ananthakrishnan, Ashwin
    Lochhead, Paul
    Chan, Andrew
    Khalili, Hamed
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S528 - S528
  • [45] The prevalence and risk factors for lymphoproliferative disease in patients with inflammatory bowel disease
    Chiorean, Michael V.
    Adabala, Jaya
    Helper, Debra J.
    Galetti, Bridget D.
    Musick, Beverly S.
    Calley, Cynthia S.
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A511 - A511
  • [46] Risk Factors for Incident Inflammatory Bowel Disease According to Disease Phenotype
    Lopes, Emily W.
    Lochhead, Paul
    Burke, Kristin E.
    Richter, James M.
    Ananthakrishnan, Ashwin N.
    Chan, Andrew T.
    Khalili, Hamed
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (10) : 2347 - +
  • [47] Geographical variability and environmental risk factors in inflammatory bowel disease
    Ng, Siew C.
    Bernstein, Charles N.
    Vatn, Morten H.
    Lakatos, Peter Laszlo
    Loftus, Edward V., Jr.
    Tysk, Curt
    O'Morain, Colm
    Moum, Bjorn
    Colombel, Jean-Frederic
    [J]. GUT, 2013, 62 (04) : 630 - 649
  • [48] Inflammatory bowel disease:Epidemiology,pathology and risk factors for hypercoagulability
    Danuta Owczarek
    Dorota Cibor
    Mikolaj K Glowacki
    Tomasz Rodacki
    Tomasz Mach
    [J]. World Journal of Gastroenterology, 2014, (01) : 53 - 63
  • [49] Risk Factors for Rectal Stump Cancer in Inflammatory Bowel Disease
    Lutgens, Maurice W. M. D.
    van Oijen, Martijn G. H.
    Vleggaar, Frank P.
    Siersema, Peter D.
    Broekman, Mark M. T. J.
    Oldenburg, Bas
    [J]. DISEASES OF THE COLON & RECTUM, 2012, 55 (02) : 191 - 196
  • [50] Multiomics to elucidate inflammatory bowel disease risk factors and pathways
    Agrawal, Manasi
    Allin, Kristine H.
    Petralia, Francesca
    Colombel, Jean-Frederic
    Jess, Tine
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (06) : 399 - 409